IFPMA facts & figures 2015

Statement 4 Aug 2026

Seventh meeting of the Subsidiary Body on Implementation (SBI-7): Digital sequence information on genetic resources

On 4 August 2026 in Nairobi, Kenya, IFPMA shared a statement at the seventh meeting of the Subsidiary Body on Implementation on digital sequence information on genetic resources. IFPMA welcomes the opportunity to address this agenda item. Our member companies support the objectives of the Convention and the Kunming-Montreal Global Biodiversity Framework. As Parties consider...

Healthy planet, healthy people: The innovative pharmaceutical industry’s contribution to the Kunming-Montreal Global Biodiversity Framework

Through company-level initiatives and decades of pre-competitive collaboration, IFPMA member companies are working to reduce environmental impact and contribute positively to a healthy and biodiverse planet.

Global biopharmaceutical CEOs response to reforms introduced in Germany

In response to reforms adopted by the German government on 10 July, BCR Secretary General, and IFPMA Director General, Dr. David Reddy, said: “The legislation passed by the German government undermines the value of medical innovation, global competitiveness and patient access to new medicines. Failing to reflect the value that medicines and vaccines bring, will negatively...